Figure 6. Relationships between risk score with clinical characteristics and immune microenvironment. (A) The risk score distribution of clinical variables which including age, clark level, tumor size, stage, radiation, vital status and metastatic status. (B) The landscape of immune infiltration between high and low risk groups in TCGA-SKCM dataset. (C) The difference of 11 immune infiltration between high and low risk groups; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.